Federal contract award

75F40125F19002

1-YEAR, TIME AND MATERIALS (T&M) TYPE TASK ORDER FOR PROJECT MANAGEMENT SUPPORT SERVICES FOR THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ).

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541611 — Administrative Management and General Management Consulting Services
PSCR499 — Other Professional Services
Parent award / vehicle75F40123D00021
Set-asideNot reported
Pricing typeTIME AND MATERIALS
Obligations$490
Current contract value$490
Potential contract value / ceiling$490
Start dateDec 16, 2024
Current end dateFeb 14, 2025
Potential end dateFeb 14, 2025
Latest award activityApr 18, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 18, 2025P00003$-291.5KCORRECT POP END DATE OF FULLY TERMINATED, 1-YEAR, TIME AND MATERIALS (T&M) TYPE TASK ORDER FOR PROJECT MANAGEMENT SUPPORT SERVICES FOR THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ).
Feb 25, 2025P00002$0CORRECT POP END DATE OF FULLY TERMINATED, 1-YEAR, TIME AND MATERIALS (T&M) TYPE TASK ORDER FOR PROJECT MANAGEMENT SUPPORT SERVICES FOR THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ).
Feb 14, 2025P00001$0TERMINATION FOR CONVENIENCE (COMPLETE). GSA MEMORANDUM PROVIDED TO FEDERAL GOVERNMENT AGENCIES REGARDING "IDENTIFICATION OF CONTRACTS THAT MAY BE WASTEFUL, UNDERUTILIZED, INEFFICIENTLY MANAGED OR INCONSISTENT WITH PRESIDENTIAL DIRECTIVES."
Dec 16, 20240$292.0K1-YEAR, TIME AND MATERIALS (T&M) TYPE TASK ORDER FOR PROJECT MANAGEMENT SUPPORT SERVICES FOR THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF PHARMACEUTICAL QUALITY (OPQ).

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.